Brain-derived peptides reduce the size of cerebral infarction and loss of MAP2 immunoreactivity after focal ischemia in rats

  • M. Schwab
  • I. Antonow-Schlorke
  • U. Zwiener
  • R. Bauer
Part of the Journal of Neural Transmission. Supplementa book series (NEURAL SUPPL, volume 53)


The effects of brain-derived peptides (BDP; Cerebrolysin®) upon the amount of brain injury due to focal brain ischemia were assessed. Male Thomae rats were divided randomly into a sham-operated group (n = 5), an ischemic control (untreated) group (n = 7) and an ischemic BDP-treated group (n = 6), and subjected to reversible middle cerebral artery occlusion (MCAO) for 2 h followed by 90 min of reperfusion. Local cortical blood flow (LCBF) was monitored by Laser-Doppler flowmetry to assess the MCAO and to measure the blood flow in regions peripheral to the infarction.

Infarcted areas of the hippocampus and subcortical structures were quantified in hematoxylin and eosin (H&E) stainings. Functional disturbances of the neurons were detected by immunohistochemical staining of the microtubule associated protein MAP2. Moreover, brain edema was estimated morphometrically.

LCBF was estimated from the periphery of infarcted areas and was reduced to 55 to 65% of baseline values (p < 0.05). Reperfusion led to LCBF being increased again to baseline values. No differences in LCBF between the control and the BDP-treated animals were found. In the hippocampus, BDP-treated animals showed a significant reduction of loss of MAP2 immunoreactivity in the subiculum and CAl region by 59% and 64%, respectively, in comparison to control animals (p < 0.05). The amount of irreversibly damaged neurons in these regions was decreased in tendency. However, the inner blade of the dentate gyrus in BDP-treated animals showed a significant reduction of neuronal injury by 98% (p < 0.05). Likewise, BDP treatment reduced the size of the areas showing a loss of MAP2 immunoreactivity in the thalamic and hypothalamic structures by 51 % and in the mesencephalon by 81 % (p < 0.05). The size of the infarcted areas in these regions (H&E) was reduced in tendency. In the caudate putamen, no protective effect of BDP-treatment could be proven. Cerebral infarction was accompanied by an increase in the volume of the ischemic hemisphere by 10 ± 1 % in the control and 8 ± 1 % in the BDP-treated animals. These findings indicate a beneficial effect for BDP treatment in ameliorating the early effects of focal brain ischemia.


Cerebral Infarction Middle Cerebral Artery Occlusion Brain Edema Focal Ischemia Cereb Blood Flow 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Akai F, Hiruma S, Sato T, Iwamoto N, Fujimoto M, Ioku M, Hashimoto S (1992) Neurotrophic factor-like effect of FPF1070 on septal cholinergic neurons after transections of fimbria-fornix in the rat brain. Histol Histopathol 7: 213–221PubMedGoogle Scholar
  2. Albrecht E, Hingel S, Crailsheim K, Windisch M (1993) The effects of Cerebrolysin on survial sprouting of neurons from cerebral hemispheres and from the brainstem of chick embryos in vitro. Adv Biosci 87: 341–342Google Scholar
  3. Astrup J, Siesjö BK, Symon L (1981) Thresholds in cerebral ischemia. The ischemic penumbra. Stroke 8: 723–725CrossRefGoogle Scholar
  4. Bartus RT, Dean RL, Cavanaugh K, Eveleth D, Carriero DL, Lynch G (1995) Time-related neuronal changes following middle cerebral artery occlusion: implications for therapeutic intervention and the role of calpain. J Cereb Blood Flow Metab 15: 969–979PubMedCrossRefGoogle Scholar
  5. Bershadsky AD, Vasiliev JM (1989) Cytoskeleton. Plenum Press, New YorkGoogle Scholar
  6. Boado RJ (1995) Brain-derived peptides regulate the steady state levels and increase stability of the blood-brain barrier GLUT1 glucose transporter mRNA. Neurosci Lett 197: 179–182PubMedCrossRefGoogle Scholar
  7. Chen H, Chopp M, Zhang ZG, Garcia JH (1992) The effect of hypothermia on transient middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 12: 621–628PubMedCrossRefGoogle Scholar
  8. DeGraba TJ, Ostrow PT, Grotta JC (1993) Threshold of calcium disturbances after focal cerebral ischemia in rats. Implications of the window of therapeutic opportunity. Stroke 24: 1212–1216Google Scholar
  9. Francis-Turner L, Valouskova V (1996) Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor can reduce spatial memory impairment elicited by fimbria-fornix transection: short-term study. Neurosci Lett 202: 193–196PubMedCrossRefGoogle Scholar
  10. Ginsberg MD (1997) Injury mechanisms in the ischaemic penumbra: approaches to neuroprotection in acute ischaemic stroke. Cerebrovasc Dis 7 [Suppl]: 7–12CrossRefGoogle Scholar
  11. Globus MY, Busto R, Martinez E, Valdes I, Dietrich WD, Ginsberg MD (1991) Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat. J Neurochem 57: 470–478PubMedCrossRefGoogle Scholar
  12. Heiss WD, Graf R, Wienhard K, Lottgen J, Saito R, Fujita T, Rosner G, Wagner R (1994) Dynamic penumbra demonstrated by sequential multitracer PET after middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab 14: 892–902PubMedCrossRefGoogle Scholar
  13. Karibe H, Zarow GJ, Graham SH, Weinstein PR (1994) Mild intraischemic hypothermia reduces postischemic hyperperfusion, delayed postischemic hypoperfusion, blood-brain barrier disruption, brain edema, and neuronal damage volume after temporary focal cerebral ischemia in rats. J Cereb Blood Flow Metab 14: 620–627PubMedCrossRefGoogle Scholar
  14. Kempski O, Heimann A, Strecker U (1995) On the number of measurements necessary to assess regional cerebral blood flow by local laser Doppler recordings: a simulation study with data from 45 rabbits. Int J Microcirc Clin Exp 15: 37–42PubMedCrossRefGoogle Scholar
  15. Kitagawa K, Matsumoto M, Niinobe M, Mikoshiba K, Hata R, Ueda H, Handa N, Fukunaga R, Isaka Y, Kimura K, et al (1989) Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage — immunohistochemical investigation of dendritic damage. Neuroscience 31: 401–411PubMedCrossRefGoogle Scholar
  16. Nedergaard M (1987) Neuronal injury in the infarct border: a neuropathological study in the rat. Acta Neuropathol 73: 267–274PubMedCrossRefGoogle Scholar
  17. Obrenovitch TP (1995) The ischaemic penumbra: twenty years on. Cerebrovasc Brain Metab Rev 7: 297–323PubMedGoogle Scholar
  18. Osborne KA, Shigeno T, Balarsky AM, Ford I, McCulloch J, Teasdale GM, Graham DI (1987) Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. J Neurol Neurosurg Psychiatr 50: 402–410PubMedCrossRefGoogle Scholar
  19. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, San DiegoGoogle Scholar
  20. Saido TC, Yokota M, Nagao S, Yamaura I, Tani E, Tsuchiya T, Suzuki K, Kawashima S (1993) Spatial resolution of fodrin proteolysis in postischemic brain. J Biol Chem 268: 25239–25243PubMedGoogle Scholar
  21. Saito R, Graf R, Hubel K, Taguchi J, Rosner G, Fujita T, Heiss WD (1995) Halothane, but not alpha-chloralose, blocks potassium-evoked cortical spreading depression in cats. Brain Res 699: 109–115PubMedCrossRefGoogle Scholar
  22. Sakurada O, Kennedy C, Jehle J, Brown JD, Carbin GL, Sokoloff L (1978) Measurement of local cerebral blood flow with iodo[14C]antipyrine. Am J Physiol 234: H59–66Google Scholar
  23. Satou T, Imano F, Akai F, Hashimoto S, et al (1993) Morphological observation of effects of Cerebrolysin on cultured neural cells. Adv Biosci 87: 195–196Google Scholar
  24. Schuier FJ, Hossmann KA (1980) Experimental brain infarcts in cats. II. Ischemic brain edema. Stroke 11: 593–601PubMedCrossRefGoogle Scholar
  25. Schwab M, Schaller R, Bauer R, Zwiener U (1997a) Morphofunctional effects of moderate forebrain ischemia combined with short-term hypoxia in rats — protective effects of Cerebrolysin. Exp Toxic Pathol 49: 29–37CrossRefGoogle Scholar
  26. Schwab M, Bauer R, Zwiener U (1997b) Physiological effects and brain protection by hypothermia and Cerebrolysin after moderate forebrain ischemia in rats. Exp Toxic Pathol 49: 105–116CrossRefGoogle Scholar
  27. Schwab M, Antonow-Schlorke I, Bauer R, Zwiener U (1998) MAP2 is an early marker of neuronal dysfunction after focal ischemia in Thomae rats. Brain Res Bull (in press)Google Scholar
  28. Shigeno T, Teasdale GM, McCulloch J, Graham DI (1985) Recirculation model following MCA occlusion in rats. Cerebral blood flow, cerebrovascular permeability, and brain edema. J Neurosurg 63: 272–277PubMedCrossRefGoogle Scholar
  29. Slivka A, Murphy E, Horrocks L (1995) Cerebral edema after temporary and permanent middle cerebral artery occlusion in the rat. Stroke 26: 1061–1065PubMedCrossRefGoogle Scholar
  30. Takagi K, Ginsberg MD, Globus MY, Dietrich WD, Martinez E, Kraydieh S, Busto R (1993) Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology. J Cereb Blood Flow Metab 13: 575–585PubMedCrossRefGoogle Scholar
  31. Verhaegen M, Todd MM, Warner DS (1994) Ischemic depolarization during halothanenitrous oxide and isoflurane-nitrous oxide anesthesia. An examination of cerebral blood flow threshold and times to depolarization. Anesthesiology 81: 965–973PubMedCrossRefGoogle Scholar
  32. Xiong H, Baskys A, Wojtowicz JM (1996) Brain-derived peptides inhibit synaptic transmission via presynaptic GABAB receptors in CA1 area of rat hippocampal slices. Brain Res 737: 188–194PubMedCrossRefGoogle Scholar
  33. Yanagihara T, Brengman JM, Mushynski WE (1990) Differential vulnerability of microtubule components in cerebral ischemia. Acta Neuropathol 80: 499–505PubMedCrossRefGoogle Scholar
  34. Zea Longa E, Weinstein PR, Cummuns RW, Carlson S (1989) A new method of middle cerebral artery oclusion in the rat without craniectomy. Stroke 20: 84–91CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 1998

Authors and Affiliations

  • M. Schwab
    • 1
    • 2
  • I. Antonow-Schlorke
    • 1
  • U. Zwiener
    • 1
  • R. Bauer
    • 1
  1. 1.Institute of PathophysiologyFriedrich Schiller UniversityJenaFederal Republic of Germany
  2. 2.Department of NeurologyFriedrich Schiller UniversityJenaFederal Republic of Germany

Personalised recommendations